Compare Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mizuho Financial Group Inc. Sponosred ADR (Japan) vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.58 (market cap $132.18B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 58× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| MFG | SLS | |
|---|---|---|
Market Cap | $132.18B | $2.28B |
Volume | 3,264,662 | 3,128,960 |
Sector | Financials | Health |
52-Week High | $11.45 | $15.46 |
52-Week Low | $6.09 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $35.48T | $2.15B |
Dividend Yield | 1.7% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
